Our triple-zero vision will not be achieved through funding alone. Our approach to resource mobilization and advocacy includes championing progress toward leprosy targets and commitments to upholding human rights, ensuring that no one is left behind. By aligning the many voices of the leprosy community, we form a powerful force for change.
Our resource mobilization and advocacy strategy supports the uptake of the Zero Leprosy Research Agenda, effective leprosy prevention and control activities at the country level, use of GPZL tools and best practices, and prioritization of leprosy on the international stage.
Fact sheet: COVID-19 Crisis and Persons Affected by Leprosy
Persons affected by leprosy have been especially impacted by the worst consequences of the pandemic, due to preexisting vulnerabilities and economic precarity.
New global leprosy data shows the path to disease elimination. This resource illustrates leprosy prevalence, recent successes, current challenges, and action needed to achieve further progress toward zero leprosy.
The Global Partnership For Zero Leprosy, a program of the Task Force for Global Health, submitted a statement to the 73rd World Health Organization (WHO) Regional Committee Meeting for the Western Pacific in October 2022. The statement refers to agenda item 14, “Reaching the unreached.” … Read More >
The Secretariat Director of the Global Partnership for Zero Leprosy, Bill Gallo, joined the World Health Organization (WHO) South East Asia Regional Committee Meeting in Paro, Bhutan in September 2022. He spoke on behalf of the Task Force for Global Health, a non-state actor, and … Read More >
On June 1 and 2 in Abidjan, a major advocacy and resource mobilization meeting took place to achieve an objective: zero leprosy in Côte d’Ivoire. These two days were a success and resulted in the signing of the “Abidjan Declaration.” The Raoul Follereau Foundation is, … Read More >
The next report of the Special Rapporteur to the United Nations General Assembly will focus on the national legal protections available for persons affected by Hansen’s disease. More specifically, the Special Rapporteur will focus on the rights provided for in the Convention on the Rights of Persons with Disabilities.